occurring at values of pH Ͼ 7.5. The optimal growth pH for M intracellulare is between 5 and 6.5. 6 Symptoms of gastroesophageal reflux disease (GERD) are reported to occur weekly in approximately 20% of the population. 9 -11 Both acid reflux and nonacid reflux have been implicated in the pathophysiology of chronic cough, asthma, idiopathic pulmonary fibrosis, and laryngeal dysfunction. 12, 13 Aspiration of upper respiratory tract bacteria into the lungs is thought to occur quite frequently (in approximately 50% of normal hosts during sleep) 14 and is generally of little consequence in the majority on individuals. Microaspiration of organisms probably occurs more frequently in the setting of altered sensorium, such as with alcohol or sedative drug use, and has been postulated as a cause of lower respiratory tract infections and chronic lung disease, 14, 15 particularly if there is a large inoculum of bacteria, solid material, or acid. Deposition of relatively few mycobacteria can infect the host; estimates range from 2 to 3 bacteria, to as many as 50. 16 Esophageal disorders, particularly achalasia, have been described in association with pulmonary disease due to rapidly growing mycobacteria. [17] [18] [19] A similar association for slow-growing mycobacteria has not been established. We postulated that if acidsuppression therapy enhances the survival of mycobacterial organisms in the stomach, then aspiration of gastric/oropharyngeal contents may be a potential portal of entry of these organisms into the respiratory tract.
The aim of this study was to assess the prevalence of a medical diagnosis of GERD, reflux symptoms, and acid-suppression therapy in patients with MAC lung disease (MAC positive [MACϩ] ), and to compare these patients with control subjects without MAC lung disease (MAC negative [MACϪ] ). We also aimed to assess the prevalence of reported swallowing disorders in these patients, who were at risk of aspiration.
Materials and Methods
A prospective cohort of 58 patients (cases) with MAC lung disease was identified by laboratory notification of isolates of MAC in Queensland, Australia between January 1 and December 31, 1999. The protocol (138/98) was approved by the Princess Alexandra Hospital Research Ethics Committee in accordance with the Australian National Health and Medical Research Council guidelines. Consent to participate was sought, and clinical features of the disease (including risk factors, symptoms, radiology, and treatment prescribed) were then provided by the treating doctor. Each patient was asked to complete a DeMeester questionnaire of reflux symptoms (Fig 1) . A maximum score of 3 points was assigned for each of heartburn, regurgitation, and dysphagia. Patients were also asked to identify from a comprehensive list any acid-suppressing medication they consumed regularly. A clinical diagnosis of GERD by the treating physician was recorded; when possible, supportive gastroscopy or pH probe findings were obtained.
Control patients (MACϪ) were recruited from the Respiratory Outpatients Clinics. Each MACϩ case was matched to a MACϪ control according to age (10-year groupings), gender, and smoking history (current smoker, ex-smoker, or nonsmoker). As other lung diseases can be associated with GERD, to minimize confounding, MACϪ control subjects were matched according to the preexisting lung disease of the MACϩ cases (eg, COPD, preexisting bronchiectasis). If patients with mycobacterial disease had no preexistent lung disease, then they were matched with control subjects also without lung disease, or in some patients with mild COPD or asthma, but with similar respiratory symptoms such as chronic cough. When the underlying lung disease was COPD or bronchiectasis, the control subjects were required to have a minimum of three negative sputa for mycobacteria within the preceding 12 months and no history of mycobacterial disease. Each MACϪ control subject was also asked to complete a DeMeester symptom questionnaire and to record any GERD medication consumed. Gastroscopy, pH probe, and radiographic contrast swallow findings were also recorded. Due to the difficulty in finding matched control subjects, they were not matched for factors such as steroid use, alcohol consumption, or diabetes; however, these were recorded and included in the statistical analysis. While obesity can be associated with an increased risk of GERD, the cases and controls were not matched according to body mass index. As most patients with MAC lung disease are thin, this would likely bias toward the null, rather than confound the findings.
MACϩ patients were classified as having cavitary disease (any cavities present, including those associated with bronchiectasis) or noncavitary disease (predominantly nodular bronchiectasis). The radiographic distribution of disease was divided into upper lobe, middle lobe (right middle lobe and lingula), and lower lobe according to the predominant diseased areas. Patients receiving medication for GERD were grouped into antacids, histamine type 2 receptor antagonists (H2RAs), proton-pump inhibitors, and prokinetic agents.
Data were analyzed using statistical software (SPSS v12.0 for Windows 2003; SPSS; Chicago, IL). Tests of association were performed using Fisher exact test for 2 two-by-two tables. DeMeester scores were compared using the Mann Whitney U test. DeMeester scores were also compared using a univariate analysis of variance that included both matched factors and 
Results
The details of MACϩ cases and MACϪ controls are shown in Table 1 . Radiologic details of those with disease (MACϩ) are shown in Table 2 and bacteriology in Table 3 .
Clinical information about reflux disease was returned for 52 of 58 MACϩ patients. Twenty-three MACϩ patients (44.2%) had a diagnosis of GERD recorded by their treating doctor, compared to 16 MACϪ patients (27.6%) [p ϭ 0.019]. Confirmatory evidence was provided in 10 MACϩ patients: 6 patients had positive findings on gastroscopy, and 4 patients had radiologic evidence on Barium swallow. Ten MACϪ patients had undergone gastroscopy, and 1 patient had a pH probe.
There were significant differences between MACϩ and MACϪ patients in the use of acid suppression, as shown in Table 4 . MACϩ patients consumed significantly more H2RAs and prokinetic agents, and MACϪ patients consumed more antacids. A logistic regression model that included both matched factors and potential confounders (alcohol intake, smoking history, underlying lung disease, and steroid use) confirmed a significant association between GERD and MAC disease (p ϭ 0.008).
DeMeester questionnaire scores are shown in Table  5 . The mean score (Ϯ SD) for MACϩ patients was 1.39 Ϯ 1.8, and for MACϪ patients was 0.88 Ϯ 1.4. As the scores were not normally distributed, they were compared using the Mann Whitney U test, which failed to show a statistically significant difference between the two groups (p ϭ 0.098). Potential differences between MACϩ and MACϪ groups were tested using an analysis of variance that included matched factors and other potential confounding factors (steroids, smoking history, underlying lung disease). There was a difference in DeMeester scores across both MACϩ and MACϪ for steroid use with significant differences between those not receiving steroids and those receiving continuous oral steroids for Ͼ 6 months (p ϭ 0.005). This difference was greater for MACϩ (p ϭ 0.007) than MACϪ (p ϭ 0.068).
Nine MACϩ patients (15.5%) were thought to aspirate for other reasons. A summary of these patients is shown in Table 6 . All of these patients had bronchiectasis and nodules; three patients also had cavities. This compared to three MACϪ patients in whom aspiration was suspected (p ϭ 0.032).
There was no association between a medical diagnosis of GERD and radiologic presentation of MAC disease according to the groups outlined in Table 2 , nor when grouped as cavitary vs noncavitary nor predominant distribution of disease (ie, upper/middle/lower lobes). More patients with consolidation on radiography consumed acid-suppressive medication regularly than those without consolidation (p ϭ 0.018). This was mainly due to the relationship between H2RA use and consolidation. Seven of 17 patients (41.2%) with consolidation on radiography were receiving H2RAs, compared to 2 of 30 patients (6.7%) without consolidation (p ϭ 0.007). Six of 11 patients (54.5%) with nodules Ͼ 5 mm consumed some form of acid suppression, compared to 8 of 36 patients (22.2%) without nodules Ͼ 5 mm (p ϭ 0.06). There was no correction made for multiple comparisons.
Discussion
GERD is a common problem in patients with a number of respiratory diseases. The mechanics of coughing and the related reduction in lower esophageal sphincter tone encourage the reflux of gastric contents into the lower esophagus. The lower pH in the distal esophagus has been shown to cause further cough. Hence, proving a connection between GERD and MAC lung disease specifically was likely to be difficult.
Patients in this cohort with pulmonary MAC disease have a higher incidence of GERD than is reported in general population surveys and when compared to a matched cohort without MAC disease. The consumption of regular acid-suppressive medication by MACϩ patients was greater than MAC-control subjects. While DeMeester questionnaire scores of gastroesophageal reflux symptoms also appeared to be greater in MACϩ than MACϪ, this failed to reach statistical significance and was accounted for by higher oral steroid use in those with higher scores. The difference however may also have been affected by the greater use of acid suppression in the MACϩ group. The consumption of acidsuppressive medication is likely to have underestimated the DeMeester questionnaire scores in these patients, although it did not abolish reflux symptoms in all patients. While the frequency of antacid use was not formally measured in either group, in the majority of patients it was not on a daily basis, suggesting that the symptoms of GERD were in fact less frequent or severe than those who required more potent and regular acid suppression. The finding of more patients receiving acid suppression among those with consolidation and nodules has not been documented before. Consolidation is not specific for mycobacterial disease, and it is possible that other aspirated pathogens were responsible for coinfection is these cases. Acid suppression may be a marker for more severe GERD and hence greater risk of microaspiration. One could not exclude an effect of acid suppression on the nature of the aspirated refluxate that may have subsequently affected the inflammatory reaction to mycobacteria in the lung. However, as no correction was made for multiple comparisons, it is possible this finding occurred by chance.
A major limitation in this observational study is how reflux was defined. The recording of a medical diagnosis of reflux and the prescription of acidsuppressing medication imply that the patients were symptomatic. However, GERD can be silent. Gastroscopy and barium contrast studies both have limitations in diagnosing reflux disease, and as a result few patients had undergone these procedures. The 24-h pH probe has been considered the "gold standard," but even with this procedure, nonacid reflux events are not recognized, the height of the reflux above the gastroesophageal junction is poorly delineated, and the physical nature of the refluxed material is not distinguished. Given the invasive nature of this investigation, in the routine management of patients the pH probe is unlikely to change management unless symptoms persist on maximal medical therapy. Therefore, as this was an observational study (not interventional), few patients had undergone pH probe monitoring. Given also that this was a cross-sectional study, the timing of the diagnosis of GERD relative to the diagnosis of Mycobacterial disease or institution of treatment was not clear. The duration of GERD symptoms was not measured by the DeMeester questionnaire but would have been useful information. It is possible that some patients had reflux symptoms as a side effect of coughing or drugs used in treatment. However, in MAC lung disease there is often a long presymptomatic phase of disease; given the problems with recall bias and the already mentioned problems with establishing a diagnosis of reflux and the presence of silent reflux, information regarding the timing of diagnosis may not have been particularly helpful. Interestingly, 9 of 58 patients (15.5%) with pulmonary MAC disease were thought to aspirate for other reasons. One must then ask, does acid suppression enhance the survival of organisms so that with repeated reflux episodes more are likely to be aspirated, or is the chance of infection related to the frequency and size of aspiration episodes of contaminated food/liquid?
In vitro work 20 would support the latter theory. M avium has been found to be naturally tolerant to pH Ͻ 3, and preadaptation, under conditions similar to the conditions where M avium is found in the environment, resulted in increased acid resistance. One would expect then that acid suppression would have little additional effect on the survival of M avium in the stomach. A Japanese study 21 found that omeprazole exhibited no significant effect on mycobacterial growth in human alveolar macrophages or on the mycobactericidal activity of clarithromycin against them.
One might conclude then that acid suppression would have little effect on the risk of acquiring MAC, as the organisms are likely to survive gastric acid anyway. However, the use of acid suppression may be a surrogate marker for more severe reflux disease and hence indicate a greater chance of microaspiration. This theory is supported by the observation of greater use of acid suppression in MACϩ patients than MACϪ control subjects, particularly prokinetic agents. The finding of a significant number of patients with nodules and bronchiectasis thought to aspirate as a result of oropharyngeal dysfunction also raises the possibility that microaspiration/macroaspiration may be a factor involved in the etiology of nodular bronchiectasis. This would make accurate assessment of reflux more important in these patients, as nonacid, liquid reflux reaching a level above the gastroesophageal junction to make aspiration likely would be of interest. Balaji and colleagues 22 described impedance technology, which has the capacity to detect all types of reflux (acid, nonacid, liquid, mixed, and air). In their evaluation of this technology in normal individuals, they showed that over half of reflux events are not detected by pH studies and liquid reflux reached to the mid and proximal esophagus 69% of the time. With the acid resistance of slow-growing mycobacteria, this technique would seem appropriate in evaluating MAC patients for reflux as a means of acquisition of mycobacterial infection. Patients presenting with MAC lung disease should be assessed for GERD and swallowing disorders, but larger prospective studies more formally evaluating these patients for swallowing disorders and GERD are warranted. 
